Clinical Trials Browser

Phase 2 × Erlotinib Hydrochloride × Dermatologic × Clear all

NCT01059305 2017-04-04

Phase II Trial of Erlotinib, Prior to Surgery or Radiation in Patients With Squamous Cell Cancers (SCC) of the Skin

Phase 2 Terminated

10 enrolled 2 charts

Skin Neoplasms

NCT00466687 2013-07-22

Erlotinib and Bevacizumab in Treating Patients With Stage IV Melanoma

Phase 2 Completed

34 enrolled 10 charts

Melanoma